1. Home
  2. GME vs EXAS Comparison

GME vs EXAS Comparison

Compare GME & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$22.07

Market Cap

11.8B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.51

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
EXAS
Founded
1996
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Electronics Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
11.0B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
GME
EXAS
Price
$22.07
$101.51
Analyst Decision
Sell
Buy
Analyst Count
1
20
Target Price
$13.50
$77.94
AVG Volume (30 Days)
6.3M
10.8M
Earning Date
12-09-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
387.37
N/A
EPS
0.83
N/A
Revenue
$3,808,200,000.00
$3,082,033,000.00
Revenue This Year
$9.86
$19.40
Revenue Next Year
$2.83
$13.51
P/E Ratio
$25.66
N/A
Revenue Growth
N/A
14.47
52 Week Low
$19.93
$38.81
52 Week High
$35.81
$101.95

Technical Indicators

Market Signals
Indicator
GME
EXAS
Relative Strength Index (RSI) 49.71 89.69
Support Level $21.50 $100.95
Resistance Level $24.00 $101.95
Average True Range (ATR) 0.83 0.34
MACD 0.01 -1.01
Stochastic Oscillator 49.46 64.50

Price Performance

Historical Comparison
GME
EXAS

About GME GameStop Corporation

GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: